MedPath
NMPA Approval

Irinotecan Hydrochloride Injection

国药准字HJ20160577

March 11, 2021

H20160577

Drug Information

盐酸伊立替康注射液

开普拓

注射剂

5ml:0.1g(按C₃₃H₃₈N₄O₆·HCl·₃H₂O计)

化学药品

March 11, 2021

March 10, 2026

Company Information

Applicant Company

Level 17 151 Clarence Street Sydney NSW 2000 AUSTRALIA

Manufacturing Company

pfizer (perth) pty limited

Technology Park, 15 Brodie Hall Drive, BENTLEY WA 6102, Australia

© Copyright 2025. All Rights Reserved by MedPath